Trial intelligence / Profile preview

Clinical pharmacology study of alectinib in ALK-positive NSCLC

jRCT2080222140Phase 1

Sponsor

Chugai Pharmaceutical Co., Ltd.

Start

Jul 2013

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1